Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China flag China · Delayed Price · Currency is CNY
65.26
+1.75 (2.76%)
Feb 3, 2026, 3:00 PM CST

Beijing Sun-Novo Pharmaceutical Research Company Description

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China.

The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and other drug molecular design and development platform; genotoxic impurity detection platform; technology platform for slow and controlled release preparations; drug synthesis platform; and synthesis technology platform.

It also offers SMO, clinical quality management, data management and statistical analysis, project management, test center, clinical research center, clinical trials, TMFDocument management, quality control, Medical Writing, medical monitoring, and pharmacovigilance services; and registration-related services for chemical drugs, biological products, and medical device products.

In addition, the company operates quantitative pharmacology platform that use technology on pharmacokinetics, pharmacodynamics, body function, disease mechanism and test process, and other information for quantitative research; and mass spectrometry, immunological analysis, cell biology, and molecular biology platforms that provide biological analysis services for large and small molecular drugs, as well as operates as a Contract Research Organization for Professional Peptide Drug Research and Development.

The company offers clinical research technology services to pharmaceutical companies and new drug research institutions.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. was founded in 2009 and is based in Beijing, China.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
CountryChina
Founded2009
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,359
CEOYujing Liu

Contact Details

Address:
Building 7
Beijing, 102200
China
Phone86 10 6074 8199
Websitesun-novo.com

Stock Details

Ticker Symbol688621
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100005139
SIC Code8731

Key Executives

NamePosition
Yujing LiuGM and Director
Huan LuoDeputy GM and Director
Yan ShaoDeputy General Manager
Guangtao HaoDeputy GM and Core Technician
Yuanbo LiDeputy General Manager
Zhi Jiao ZhangAccounting Supervisor and Director
Li Ping WeiSecretary and Director
Ming Juan WangCore Technical Staff
Dao Sheng XieCore Technical Staff